Registro:

Referencias:

• Santen, R.J., Song, R.X., Zhang, Z., Kumar, R., Jeng, M.H., Masamura, A., Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity (2005) Endocr Relat Cancer, 12 (SUPPL. 1), pp. S61-S73. , doi: 10.1677/erc.1.01018
• Osborne, C.K., Schiff, R., Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer (2003) Breast, 12, pp. 362-367. , doi:10.1016/S0960-9776(03)00137-1
• Normanno, N., Di Maio, M., De Maio, E., De Luca, A., De Matteis, A., Giordano, A., Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer (2005) Endocr Relat Cancer, 12, pp. 721-747. , doi:10.1677/erc.1.00857
• Haslam, S.Z., Progesterone effects on deoxyribonucleic acid synthesis in normal mouse mammary glands (1988) Endocrinology, 122, pp. 464-470
• Lydon, J.P., Demayo, F.J., Funk, C.R., Mani, S.K., Hughes, A.R., Montgomery Jr., C.A., Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities (1995) Genes Dev, 9, pp. 2266-2278. , doi:10.1101/gad.9.18.2266
• Montero, G.G., Vanzulli, S.I., Cerliani, J.P., Bottino, M.C., Bolado, J., Vela, J., Association of estrogen receptor alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: Role of the host microenvironment (2007) Breast Cancer Res, 9, pp. R22. , doi:10.1186/bcr1660
• Kordon, E.C., Molinolo, A.A., Pasqualini, C.D., Charreau, E.H., Pazos, P., Dran, G., Progesterone induction of mammary carcinomas in BALB/c female mice, Correlation between progestin dependence and morphology (1993) Breast Cancer Res Treat, 28, pp. 29-39. , doi:10.1007/BF00666353
• Moore, M.R., A rationale for inhibiting progesterone-related pathways to combat breast cancer (2004) Curr Cancer Drug Targets, 4, pp. 183-189. , doi:10.2174/1568009043481515
• Lanari, C., Molinolo, A.A., Pasqualini, C.D., Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice (1986) Cancer Lett, 33, pp. 215-223. , doi:10.1016/0304-3835(86)90027-3
• Lanari, C., Molinolo, A., Diverse activation pathways for the progesterone receptor: Possible implications for breast biology and cancer (2002) Breast Cancer Res, 4, pp. 240-243. , doi:10.1186/bcr539
• Aldaz, C.M., Liao, Q.Y., Labate, M., Johnston, D.A., Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene (1996) Carcinogenesis, 17, pp. 2069-2072. , doi:10.1093/carcin/17.9.2069
• Health Initiative, W., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial (2002) JAMA, 288, pp. 321-333. , doi:10.1001/jama.288.3.321
• Beral, V., Breast cancer and hormone-replacement therapy in the Million Women Study (2003) Lancet, 362, pp. 419-427. , doi: 10.1016/S0140-6736(03)14596-5
• Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B (1990) EMBO J, 9, pp. 1603-1614
• Leo, J.C., Lin, V.C., The activities of progesterone receptor isoform A and B are differentially modulated by their ligands in a gene-selective manner (2008) Int J Cancer, 122, pp. 230-243. , doi:10.1002/ijc.23081
• Richer, J.K., Jacobsen, B.M., Manning, N.G., Abel, M.G., Wolf, D.M., Horwitz, K.B., Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells (2002) J Biol Chem, 277, pp. 5209-5218. , doi:10.1074/jbc.M110090200
• Shyamala, G., Yang, X., Silberstein, G., Barcellos-Hoff, M.H., Dale, E., Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands (1998) Proc Natl Acad Sci USA, 95, pp. 696-701. , doi:10.1073/pnas.95.2.696
• Shyamala, G., Yang, X., Cardiff, R.D., Dale, E., Impact of progesterone receptor on cell-fate decisions during mammary gland development (2000) Proc Natl Acad Sci USA, 97, pp. 3044-3049. , doi: 10.1073/pnas.97.7.3044
• Mulac-Jericevic, B., Lydon, J.P., Demayo, F.J., Conneely, O.M., Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform (2003) Proc Natl Acad Sci USA, 100, pp. 9744-9749. , doi:10.1073/pnas.1732707100
• Hopp, T.A., Weiss, H.L., Hilsenbeck, S.G., Cui, Y., Allred, D.C., Horwitz, K.B., Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates (2004) Clin Cancer Res, 10, pp. 2751-2760. , doi:10.1158/1078-0432.CCR-03-0141
• Long, B.J., Jelovac, D., Handratta, V., Thiantanawat, A., MacPherson, N., Ragaz, J., Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model (2004) J Natl Cancer Inst, 96, pp. 456-465
• MacEdo, L.F., Sabnis, G.J., Goloubeva, O.G., Brodie, A., Combination of anastrozole with fulvestrant in the intratumoral aromatase xenograft model (2008) Cancer Res, 68, pp. 3516-3522. , doi: 10.1158/0008-5472.CAN-07-6807
• Beeram, M., Tan, Q.T., Tekmal, R.R., Russell, D., Middleton, A., Degraffenried, L.A., Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling (2007) Ann Oncol, 18, pp. 1323-1328. , doi:10.1093/annonc/mdm170
• Boylan, M., Van Den Berg, H.W., Lynch, M., The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: Growth stimulation in the presence of tamoxifen (1998) Ann Oncol, 9, pp. 205-211. , doi:10.1023/A:1008241804078
• Lin, X., Yu, Y., Zhao, H., Zhang, Y., Manela, J., Tonetti, D.A., Overexpression of PKCalpha is required to impart estradiol inhibition and tamoxifen-resistance in a T47D human breast cancer tumor model (2006) Carcinogenesis, 27, pp. 1538-1546. , doi:10.1093/carcin/bgl002
• Naundorf, H., Fichtner, I., Saul, G.J., Haensch, W., Buttner, B., Establishment and characteristics of two new human mammary carcinoma lines serially transplantable in nude mice (1993) J Cancer Res Clin Oncol, 119, pp. 652-656. , doi:10.1007/BF01215983
• Molinolo, A.A., Lanari, C., Charreau, E.H., Sanjuan, N., Pasqualini, C.D., Mouse mammary tumors induced by medroxyprogesterone acetate: Immunohistochemistry and hormonal receptors (1987) J Natl Cancer Inst, 79, pp. 1341-1350
• Vanzulli, S.I., Soldati, R., Meiss, R., Colombo, L., Molinolo, A.A., Lanari, C., Estrogen or antiprogestin treatment induces complete regression of pulmonary and axillary metastases in an experimental model of breast cancer progression (2005) Carcinogenesis, 26, pp. 1055-1063. , doi:10.1093/carcin/bgi060
• Simian, M., Molinolo, A., Lanari, C., Involvement of matrix metalloproteinase activity in hormone-induced mammary tumor regression (2006) Am J Pathol, 168, pp. 270-279. , doi:10.2353/ajpath.2006. 050012
• Fabris, V.T., Benavides, F., Conti, C., Merani, S., Lanari, C., Cytogenetic findings, Trp53 mutations, and hormone responsiveness in a medroxyprogesterone acetate induced murine breast cancer model (2005) Cancer Genet Cytogenet, 161, pp. 130-139. , doi: 10.1016/j.cancergencyto.2005.02.008
• Institute of Laboratory Animal Resources CoLSNRC (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, DC; Kordon, E.C., Guerra, F., Molinolo, A.A., Charreau, E.H., Pasqualini, C.D., Pazos, P., Effect of sialoadenectomy on medroxyprogesterone-acetate-induced mammary carcinogenesis in BALB/c mice. Correlation between histology and epidermalgrowth- factor receptor content (1994) Int J Cancer, 59, pp. 196-203. , doi: 10.1002/ijc.2910590210
• Helguero, L.A., Viegas, M., Asaithamby, A., Shyamala, G., Lanari, C., Molinolo, A.A., Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment (2003) Breast Cancer Res Treat, 79, pp. 379-390. , doi:10.1023/A:1024029826248
• Vanzulli, S., Efeyan, A., Benavides, F., Helguero, L., Peters, G., Shen, J., P21, p27 and p53 in estrogen and antiprogestininduced tumor regression of experimental mouse mammary ductal carcinomas (2002) Carcinogenesis, 23, pp. 749-757. , doi:10.1093/carcin/23.5.749
• Liu, W., Bagaitkar, J., Watabe, K., Roles of AKT signal in breast cancer (2007) Front Biosci, 12, pp. 4011-4019. , doi:10.2741/2367
• Montecchia, M.F., Lamb, C., Molinolo, A.A., Luthy, I.A., Pazos, P., Charreau, E., Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas (1999) J Steroid Biochem Mol Biol, 68, pp. 11-21. , doi: 10.1016/S0960-0760(98)00166-6
• Aupperlee, M.D., Smith, K.T., Kariagina, A., Haslam, S.Z., Progesterone receptor isoforms A and B: Temporal and spatial differences in expression during murine mammary gland development (2005) Endocrinology, 146, pp. 3577-3588. , doi:10.1210/en.2005-0346
• Horwitz, K.B., Tung, L., Takimoto, G.S., Novel mechanisms of antiprogestin action (1996) Acta Oncol, 35, pp. 129-140. , doi:10.3109/02841869609098493
• Lamb, C.A., Helguero, L.A., Giulianelli, S., Soldati, R., Vanzulli, S.I., Molinolo, A., Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice (2005) Breast Cancer Res, 7, pp. R1111-R1121. , doi:10.1186/bcr1345
• Dran, G., Luthy, I.A., Molinolo, A.A., Charreau, E.H., Pasqualini, C.D., Lanari, C., Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma (1995) Breast Cancer Res Treat, 35, pp. 173-186. , doi:10.1007/BF00668207
• Arruvito, L., Giulianelli, S., Flores, A.C., Paladino, N., Barboza, M., Lanari, C., NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis (2008) J Immunol, 180, pp. 5746-5753
• Ingle, J.N., Ahmann, D.L., Green, S.J., Edmonson, J.H., Bisel, H.F., Kvols, L.K., Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer (1981) N Engl J Med, 304, pp. 16-21
• Carter, A.C., Sedransk, N., Kelley, R.M., Ansfield, F.J., Ravdin, R.G., Talley, R.W., Potter, N.R., Diethylstilbestrol recommended dosages for different categories of breast cancer patients (1977) Report of the Cooperative Breast Cancer Group. JAMA, 237, pp. 2079-2085
• Beex, L., Pieters, G., Smals, A., Koenders, A., Benraad, T., Kloppenborg, P., Tamoxifen versus ethinyl estradiol in the treatment of postmenopausal women with advanced breast cancer (1981) Cancer Treat Rep, 65, pp. 179-185
• Lonning, P.E., Taylor, P.D., Anker, G., Iddon, J., Wie, L., Jorgensen, L.M., High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy (2001) Breast Cancer Res Treat, 67, pp. 111-116. , doi:10.1023/A:1010619225209
• Conneely, O.M., Jericevic, B.M., Lydon, J.P., Progesterone receptors in mammary gland development and tumorigenesis (2003) J Mammary Gland Biol Neoplasia, 8, pp. 205-214. , doi:10.1023/A1025952924864
• Weigel, R.J., Deconinck, E.C., Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma (1993) Cancer Res, 53, pp. 3472-3474
• Ferguson, A.T., Lapidus, R.G., Davidson, N.E., Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression (1998) Oncogene, 17, pp. 577-583. , doi: 10.1038/sj.onc.1201961
• Martin, L.A., Farmer, I., Johnston, S.R., Ali, S., Dowsett, M., Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation (2005) Endocr Relat Cancer, 12 (SUPPL. 1), pp. S75-S84. , doi:10.1677/erc.1.01023
• Brodie, A., Sabnis, G., Jelovac, D., Aromatase and breast cancer (2006) J Steroid Biochem Mol Biol, 102, pp. 97-102. , doi:10.1016/j. jsbmb.2006.09.002
• Qiu, M., Olsen, A., Faivre, E., Horwitz, K.B., Lange, C.A., Mitogen activated protein kinase regulates nuclear association of human progesterone receptors (2003) Mol Endocrinol, 17, pp. 628-642. , doi: 10.1210/me.2002-0378
• Labriola, L., Salatino, M., Proietti, C.J., Pecci, A., Coso, O.A., Kornblihtt, A.R., Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells (2003) Mol Cell Biol, 23, pp. 1095-1111. , doi:10.1128/MCB.23.3.1095-1111.2003
• Faivre, E.J., Daniel, A.R., Hillard, C.J., Lange, C.A., Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors (2008) Mol Endocrinol, 22, pp. 823-837. , doi:10.1210/me.2007-0437
• Tokunaga, E., Kimura, Y., Mashino, K., Oki, E., Kataoka, A., Ohno, S., Activation of PI3K/Akt signaling and hormone resistance in breast cancer (2006) Breast Cancer, 13, pp. 137-144. , doi: 10.2325/jbcs.13.137
• Toker, A., Yoeli-Lerner, M., Akt signaling and cancer: Surviving but not moving on (2006) Cancer Res, 66, pp. 3963-3966. , doi: 10.1158/0008-5472.CAN-06-0743

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------